Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools

Table 2 Factors which make up other elements of the QRISK2® score

	AATD	Non-AATD COPD	Healthy controls	p value
Diabetes status				0.1771
None	217 (95%)	45 (90%)	44 (86%)
Type 1	2 (0.9%)	1 (2%)	1 (2%)
Type 2	9 (4%)	4 (8%)	6 (12%)
Angina or heart attack in a first degree relative < 60 years	13 (6%)	4 (8%)	3 (6%)	0.627
Chronic kidney disease	2 (0.9%)	1 (2%)	0
Atrial fibrillation	5 (2%)	1 (2%)	0
Rheumatoid arthritis	1 (0.4%)	0	0
Treated for hypertension	50 (22%)	13 (26%)	6 (12%)	0.174

Demographic data was collected for the QRISK2® score and compared across groups. Comparisons could only be made where sufficient numbers were included. Differences were compared with Fisher Exact tests and Chi squared

ISSN: 1750-1172